Profile picture

Miss Maria Josefa Sanchez

Vega Baja Hospital in Orihuela, Orihuela (Spain)
Follow
Logo ESC

Contributor content

Usefulness of red cell distribution width for predicting type of death in patients with acute coronary syndrome
Presentation
Usefulness of red cell distribution width for predicting type of death in patients with acute coronary syndrome
Prolonged hospital stay in patients with acute coronary syndrome: prevalence and clinical determinants.
Presentation
Prolonged hospital stay in patients with acute coronary syndrome: prevalence and clinical determinants.
Usefulness of GRACE and CRUSADE risk scores in patients with chronic obstructive pulmonary disease and acute coronary syndrome.
Presentation
Usefulness of GRACE and CRUSADE risk scores in patients with chronic obstructive pulmonary disease and acute coronary syndrome.
Acutely decompensated heart failure readmission at 1-year in patients with acute coronary syndrome.
Presentation
Acutely decompensated heart failure readmission at 1-year in patients with acute coronary syndrome.
In-hospital heart failure in a contemporary cohort of patients admitted for acute coronary syndrome: incidence and clinical determinants
Presentation
In-hospital heart failure in a contemporary cohort of patients admitted for acute coronary syndrome: incidence and clinical determinants
Influence of diabetes status on prescription of antiplatelet therapy in patients with acute coronary syndrome.
Presentation
Influence of diabetes status on prescription of antiplatelet therapy in patients with acute coronary syndrome.
Additional prognostic value of red cell distribution width on independent hemoglobin anemic state in patients with acute coronary syndrome.
Presentation
Additional prognostic value of red cell distribution width on independent hemoglobin anemic state in patients with acute coronary syndrome.
Influence of bleeding and ischemic risk on the prescription of new antiplatelets in patients with acute coronary syndrome
Presentation
Influence of bleeding and ischemic risk on the prescription of new antiplatelets in patients with acute coronary syndrome

ESC 365 is supported by